Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moderna Therapeutics
Biotech
PitchBook expects disciplined biopharma VC recovery in 2026
The biopharma VC market reflected a preference for de-risked assts over platforms and predicted a “continued, albeit disciplined” recovery in 2026.
Will Maddox
Feb 16, 2026 12:01am
Addition Tx does the math and emerges from stealth with $100M
Dec 17, 2025 7:45am
mRNA biotech Exsilio breaks cover with Tal Zaks at the helm
Jun 25, 2024 5:00am
Moderna's one-two COVID-flu punch matches existing vaccines
Oct 4, 2023 9:55am
Early mRNA vaccine breakthrough wins Nobel Prize for medicine
Oct 2, 2023 8:15am
CureVac hand-picks mRNA flu vaccine but keeps data tucked away
Sep 12, 2023 10:45am
